Trial Information
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Inclusion Criteria:
- any patient diagnosed with Gastric (stomach) Cancer, Esophageal (foodpipe) Cancer,
Pancreas Cancer, Liver Cancer, Biliary (gallbladder) Cancer, Gastrointestinal Stromal
Tumor, Peritoneal Mesothelioma (cancer in the lining of the abdomen), Neuroendocrine
(of or relating to the cells that release a hormone into the blood in response to a
neural stimulus) Tumor, Anal Cancer or Colorectal Cancer cancer that requires you to
undergo a surgical or diagnostic procedure.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Collect and store blood samples
Outcome Description:
To collect and store blood samples from patients with gastric cancer, GIST, esophageal cancer, pancreas cancer, hepatocellular cancer, biliary cancer, neuroendocrine, peritoneal mesothelioma, anal cancer and colorectal cancer.
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Daniel Catenacci, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Chicago
Authority:
United States: Institutional Review Board
Study ID:
16294A
NCT ID:
NCT01416714
Start Date:
June 2008
Completion Date:
October 2016
Related Keywords:
- Gastric Cancers
- Anus Neoplasms
- Colorectal Neoplasms
- Esophageal Neoplasms
- Liver Neoplasms
- Stomach Neoplasms
- Mesothelioma
- Pancreatic Neoplasms
- Gastrointestinal Stromal Tumors
- Gastrointestinal Neoplasms
Name | Location |
The University of Chicago |
Chicago, Illinois 60637 |